P. Kendall‐Taylor

Medicine · Health Sciences

39h-index5.1kcitations164works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pituitary Gland Disorders and Treatments(43), Thyroid Disorders and Treatments(38), Growth Hormone and Insulin-like Growth Factors(32), Ophthalmology and Eye Disorders(24), Adrenal Hormones and Disorders(14)

Publications164 total

The Diagnostic Value of Antibody Tests in Graves� Ophthalmopathy1
Developments in ophthalmology·2015· 1 cited
Autoantibodies to Eye Muscle and Orbital Fibroblasts in the Pathogenesis of Thyroid-Associated Ophthalmopathy
Experimental and Clinical Endocrinology & Diabetes·2009· 3 cited
Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on the management of GO
Endocrinología y Nutrición·2008
The role of the <i>IDDM2</i> locus in the susceptibility of UK APS1 subjects to type 1 diabetes mellitus
International Journal of Immunogenetics·2007· 15 citedOpen Access
Clinical assessment of patients with Graves’ orbitopathy: the European Group on Graves’ Orbitopathy recommendations to generalists, specialists and clinical researchers
European Journal of Endocrinology·2006· 286 cited
A questionnaire survey on the management of Graves’ orbitopathy in Europe
European Journal of Endocrinology·2006· 75 cited
Genetics factors in thyroid disease
2005
CTLA4 gene and Graves’ disease: association of Graves’ disease with the CTLA4 exon 1 and intron 1 polymorphisms, but not with the promoter polymorphism
Clinical Endocrinology·2003· 63 cited
Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: the first European Group on Graves' Orbitopathy experience
European Journal of Endocrinology·2003· 209 cited
Prophylactic steroids are unnecessary in patients with thyroid-associated ophthalmopathy receiving radioiodine therapy
22nd Joint Meeting of the British Endocrine Societies·2003
Managing differentiated thyroid cancer
BMJ·2002· 13 citedOpen Access
Genome Screening for Graves’ Disease Susceptibility Loci in U.K. Families
2002
Medical therapy of macroprolactinomas in men: (1) prevalence of hypopituitarism at diagnosis and (2) proportion of cases exhibiting recovery of pituitary function
192nd Meeting of the Society for Endocrinology·2001
Pan-Hypopituitarism and Diabetes Insipidus after a Heart Transplant
Journal of the Royal Society of Medicine·2001Open Access
<i>Clinical Endocrinology</i> goes electronic
Clinical Endocrinology·2001· 17 cited
Thyroid cancer in the UK: can we do it better?
Clinical Endocrinology·2001· 9 cited
Transsphenoidal pituitary surgery in Cushing's disease: can we predict outcome?
Clinical Endocrinology·2001· 183 cited
Management of a pregnant patient with Graves' disease complicated by thionamide‐induced neutropenia in the first trimester
Clinical Endocrinology·2001· 18 cited
Clinical Presentation and Natural History of Graves’ Ophthalmopathy
Endocrine updates·2001· 5 cited
Optimizing the Management of Differentiated Thyroid Cancer
Clinical Oncology·2000· 6 cited
page 1 of 9Next →

Frequent Co-authors

Petros Perros(8), Amanda Dickinson(4), Richard C. Trembath(4), Ashley Grossman(4), William Reardon(4), Philip E. Harris(4), M. C. White(4), L. Baldeschi(3), G. E. Krassas(3), John H. Lazarus(3), Marco Nardi(3), Jacques Orgiazzi(3), A L Crombie(3), Peter Phelps(3), Linda Luxon(3), Rebecca Coffey(3), Roberta James(3), W. M. Ross(3), Bijay Vaidya(3), E. T. Young(3)